| Document Date: 2014-07-15 12:41:52
Open Document File Size: 497,42 KBShare Result on Facebook
City Portland / / Company Gould / McDonald LC / Gagnon S / CDI / / Continent America / / Country United States / Canada / / Currency USD / / / Event FDA Phase / / / IndustryTerm healthcare facility / healthcare-associated infections / healthcare / Healthcare facilities / healthcare workers / healthcare epidemiology / healthcare settings / healthcare providers / / MedicalCondition C CLOSTRIDIUM DIFFICILE INFECTION / difficile infections / watery diarrhea / lostridium difficile infection / postal worker injuries / C. difficile infections / difficile infection / inflammatory mediators / difficile colitis / observed infections / fulminant colitis / illness / infections / diarrheal disease / toxic megacolon / Malisiovas N. Clostridium difficile infection / disease / serious underlying illness / healthcare-associated infections / viral infections / infectious diseases / infection / C. difficile disease / inflammation / / MedicalTreatment antibiotics / gastrointestinal surgery / / Organization OREGON PUBLIC HEALTH DIVISION / FDA / Oregon Health Authority / / / Position treating physician / / Product metronidazole / TREATMENT OF CDI Oral / Investigational New Drug / / ProvinceOrState Deschutes / Quebec / Deschutes County / Oregon / Klamath County / Klamath / Arkansas / / Technology transplantation / / URL www.cdc.gov/vitalsigns/pdf/2012-03-vitalsigns.pdf / http /
SocialTag |
oregon_health_authority_final_black and white all black